COMBINED USE OF TGF-B SIGNALING INHIBITOR AND ANTITUMOR AGENT

摘要

The combined use of a TGF-&bgr; signaling inhibitor and an antitumor active substance or an imaging agent modified by a drug-encapsulating macromolecular micelle, or the like, is provided. The selective delivery capability of the antitumor active substance or the imaging agent to the target is improved, increasing the antitumoral activity in the target.